UK markets closed

Silence Therapeutics plc (SLNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
8.000.00 (0.00%)
At close: 12:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
16,150
25,375
17,501
12,415
5,479
Cost of revenue
9,063
10,318
10,880
7,456
3,762
Gross profit
7,087
15,057
6,621
4,959
1,717
Operating expenses
Research development
34,430
44,025
35,605
30,765
20,209
Selling general and administrative
21,552
20,636
19,609
20,008
13,983
Total operating expenses
55,982
64,661
55,214
50,773
37,564
Operating income or loss
-48,895
-49,604
-48,593
-45,814
-35,847
Interest expense
-44
34
47
8
16
Total other income/expenses net
-2,118
-2,118
1,046
-44
-307
Income before tax
-43,545
-50,310
-47,368
-45,856
-36,041
Income tax expense
-7,385
-7,043
-6,879
-6,446
-3,494
Income from continuing operations
-36,160
-43,267
-40,489
-39,410
-32,547
Net income
-36,160
-43,267
-40,489
-39,410
-32,547
Net income available to common shareholders
-36,160
-43,267
-40,489
-39,410
-32,547
Basic EPS
-0.42
-
-0.42
-0.44
-0.40
Diluted EPS
-0.42
-
-0.42
-0.44
-0.40
Basic average shares
96,585
-
96,585
88,950
81,772
Diluted average shares
96,585
-
96,585
88,950
81,772